House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Endocrinology · RSSDI

Glucose monitoring in diabetes

RSSDI
A
Source:RSSDI Expert Consensus for Optimal Glucose Monitoring in Diabetes (2024)ADA Standards of Care 2026
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Recurrent or severe hypoglycaemia (≥1 episode <54 mg/dL or any requiring assistance) — escalate to CGM; reassess insulin or sulfonylurea doses[1]
  • Hypoglycaemia unawareness (no symptoms below 70 mg/dL) — strict avoidance of further hypoglycaemia for 2–3 weeks; CGM essential[1]
  • DKA or HHS history despite reportedly good adherence — CGM uncovers nocturnal patterns, missed insulin, and misalignment of food and dosing[1]
  • Pregnancy with T1DM or insulin-treated T2DM — CGM with time-in-range >70% target reduces large-for-gestational-age infants[1]

First-line treatment

Interventions

  • Structured fingerstick SMBG[1]
    T1DM: 4–10 tests/day. T2DM on insulin: pre-meal and bedtime. T2DM on oral therapy: paired pre-/post-prandial during structured education only — routine SMBG without structured use does not improve outcomes
  • Continuous glucose monitoring (CGM)[1]
    Real-time CGM (Dexcom G7, Libre 3) or intermittently scanned (FreeStyle Libre 2) — all T1DM; insulin-treated T2DM with frequent hypoglycaemia or HbA1c persistently above target; pregnancy
  • Hybrid closed-loop (automated insulin delivery) systems[1]
    T1DM with frequent hypoglycaemia or wide glucose variability; specialist initiation; significantly reduces hypoglycaemia and improves TIR
  • Structured CGM data interpretation[1]
    Ambulatory glucose profile (AGP) review with patient at every visit — identify post-prandial spikes, dawn phenomenon, nocturnal hypoglycaemia; adjust regimen accordingly
  • Targets per population[1]
    General adults: HbA1c <7%, TIR ≥70%. Older or frail: HbA1c <8%, TIR ≥50%. Pregnancy: HbA1c <6.5%, TIR (63–140 mg/dL) ≥70%

Safety-net

  1. Calibrate CGM as per device instructions; trust validated devices but verify with fingerstick if symptoms don't match the reading[1]
  2. If hypoglycaemia symptoms occur — eat 15g rapid-acting carbohydrate, recheck in 15 min, repeat as needed; severe (loss of consciousness) needs glucagon or A&E[1]
  3. Sick-day rules: check glucose more frequently when ill; ketone testing if T1DM with glucose >250[1]

Referral criteria

  • Recurrent severe hypoglycaemia or hypoglycaemia unawarenessDiabetes specialist for CGM and possible hybrid closed-loop[1]
  • Pregnancy with insulin-treated diabetesJoint diabetes-obstetric care with CGM[1]
  • T1DM not on CGMDiabetes specialist for CGM initiation[1]
  • T2DM with persistent above-target HbA1c despite multiple agentsDiabetes specialist; consider CGM diagnostically[1]

Clinical summary

Self-monitoring strategies for diabetes — fingerstick blood glucose, continuous glucose monitoring (CGM), and HbA1c surveillance with structured interpretation.

References

  1. 1.RSSDI Expert Consensus for Optimal Glucose Monitoring in Diabetes (2024); ADA Standards of Care 2026 (2024)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References